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糖尿病患者における下肢切断部位および再切断率の
23年間にわたる経時的変化
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Objective: To examine the time-dependent changes in the incidence of major amputation and re-amputation
in diabetic patients who underwent lower extremity amputation (LEA).
Method:We recruited 188 consecutive patients who underwent LEA due to diabetic foot ulcers at the foot
care unit in the Diabetes Center of Tokyo Women’s Medical University Hospital between 1993 and 2016. Patients
were classified into three groups according to the amputation date: group 1: 1993-2000 (n=37), group 2: 2001-2008
(n=64) and group 3: 2009-2016 (n=87). Major amputation was defined as an amputation above the ankle, and re-
amputation was defined as LEA of the same limb within 6 months after the first LEA. The time-dependent
changes in each group were compared by Jonckheere-Terpstra test.
Result: The ratio of the major amputation at the final LEA during each group were 81.1 % in group 1, 70.3 %
in group 2 and 34.5 % in group 3, and it was significantly reduced over time (p for trend＜ 0.001)．The ratio of the
re-amputations during each group were 29.7 % in group 1, 26.6 % in group 2 and 33.3 % in group 3, and there were
not any significant difference between 3 groups (p for trend = 0.510) . As for the re-amputation parts of re-
amputation patients, major amputations were performed 90.9 % in group 1, 82.4 % in group 2 and 41.4 % in group
3, and it was significantly reduced over time (p for trend = 0.001).
Conclusion: The incidence of major amputation in the diabetic patient who underwent LEA was reduced
over time. Although there were not any significant change with the incidence of re-amputation, but the incidence
of major amputation at the re-amputation parts was reduced.
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Age (years) 61±9 64±13 63±12 0.536
Male (%) 86 80 76 0.420
Type 2 diabetes (%) 92 94 92 0.876
Duration of diabetes (years) 20±9 21±11 22±11 0.582
HbA1c (%) 7.7±2.0 7.5±1.9 7.7±2.1 0.838
Dialysis (%) 65 53 46 0.165
History of cardiovascular disease (%) 68 56 57 0.512
History of leg revascularization (%)  0  9 57 ＜0.001
Smoking (current or ever) 68 55 66 0.310
Wagner grade 4 or 5 (%) 89 91 90 1.000
Group 1: 1993-2000, Group 2: 2001-2008, Group 3: 2009-2016.






























































名（39.4 %），小切断が 114名（60.6 %）であった．
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Fig.　1　Amputation level of each group
a: First amputation level, b: Final amputation level.
Major amputation was defined as an amputation above the ankle, and minor amputation 
was defined as an amputation under the ankle. The ratio of the major amputation during 
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Fig.　2　Re-amputation rate of each group
Re-amputation was defined as LEA of the same limb 
within 6 months after the first LEA. The ratio of the 
re-amputations during each group were not any signif-





























59.5 %（22名），2期：51.6 %（33名），3期：21.8 %




た（p for trend＜ 0.001）（Fig. 1）．多 変 量 ロ ジ ス
ティック回帰分析において，1期を対照とした最終
的に大切断に至るオッズ比は，2期：0.65（95％CI：






3群間に差を認めなかった（p for trend= 0.510）（Fig.
2）．再切断患者の初回切断部位は，1期 11名中 2




2.30，p = 0.853），3期：1.31（95 %CI：0.55 ― 3.11，p
= 0.539）であり，これも経時的な変化を認めなかっ
た（p for trend = 0.539）．
次に，再切断患者においてその最終切断部位を検
討したところ，1期 11名中 10名（90.9 %），2期 17
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Fig.　3　Final re-amputation level of each group
The ratio of major amputations in final re-amputation 























名中 14名（82.4 %），3期 29名中 12名（41.4 %）が
最終的に大切断となり，経時的に有意な低下を認め
た（p for trend = 0.001）（Fig. 3）．多 変 量 ロ ジ ス
ティック回帰分析において，1期を対照とした最終
的に大切断に至るオッズ比は，2期：0.66（95％CI：
0.05 ― 8.75，p = 0.754），3期：0.07（95 %CI：0.01 ―
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